Bioactivity | α-Conotoxin PeIA is an analgesic α-conotoxin.α-Conotoxin PeIA inhibits the α6β4, α9α10 and α3β2 nAChR.α-Conotoxin PeIA is also a potent inhibitor of N-type calcium channel via GABAB receptor activation[1][2][3]. |
Name | α-Conotoxin PeIA |
CAS | 866876-88-2 |
Sequence | Gly-Cys-Cys-Ser-His-Pro-Ala-Cys-Ser-Val-Asn-His-Pro-Glu-Leu-Cys-NH2 (Disulfide bridge: Cys2-Cys8, Cys3-Cys16) |
Shortening | GCCSHPACSVNHPELC-NH2 (Disulfide bridge: Cys2-Cys8, Cys3-Cys16) |
Formula | C65H98N22O21S4 |
Molar Mass | 1651.87 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Daly NL, et al. Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels. J Biol Chem. 2011 Mar 25;286(12):10233-7. [2]. Hone AJ, et al. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors. J Biol Chem. 2018 Nov 16;293(46):17838-17852. [3]. Bony AR, et al. Analgesic α-conotoxins modulate native and recombinant GIRK1/2 channels via activation of GABAB receptors and reduce neuroexcitability. Br J Pharmacol. 2022 Jan;179(1):179-198. |